APO Research
Talk to an analyst

APO RESEARCH · REPORT

Skin Active Delivery System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Skin Active Delivery System Market Analysis and Forecast 2026-2032

5 March 2026201 pages

Choose your research edition.

Industry ResearchSkin Active Delivery System Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Skin Active Delivery System Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Skin Active Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skin Active Delivery System Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Skin Active Delivery System Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Skin Active Delivery System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Skin Active Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Skin Active Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Skin Active Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Skin Active Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Skin Active Delivery System include KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Corium, Nitto, Valeritas, Nanopass Technologies, TheraJect, Inc and Vaxxas, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Skin Active Delivery System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Skin Active Delivery System, also provides the revenue of main regions and countries. Of the upcoming market potential for Skin Active Delivery System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Skin Active Delivery System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Skin Active Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Skin Active Delivery System revenue, projected growth trends, production technology, application and end-user industry.

Skin Active Delivery System Segment by Company

KINDEVA

Zosano Pharma

Becton-Dickinson(BD)Technologies

Corium

Nitto

Valeritas

Nanopass Technologies

TheraJect, Inc

Vaxxas

Microdermics

Lohmann Therapie-Systeme AG

BASF

3M

Evonik Personal Care

Vantage Personal Care

Minerals Technologies

Bicosome

Skin Active Delivery System Segment by Type

Microcapsules

Base Oil

Microneedle Technology

Skin Active Delivery System Segment by Application

Drug

Cosmetic

Skin Active Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Active Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skin Active Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Active Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Skin Active Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Skin Active Delivery System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Skin Active Delivery System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Skin Active Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microcapsules Major Player Table 3. Base Oil Major Player Table 4. Microneedle Technology Major Player Table 5. Global Skin Active Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Major Player Table 7. Cosmetic Major Player Table 8. Skin Active Delivery System Industry Trends Table 9. Skin Active Delivery System Industry Drivers Table 10. Skin Active Delivery System Industry Opportunities and Challenges Table 11. Skin Active Delivery System Industry Restraints Table 12. Global Skin Active Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Skin Active Delivery System Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Skin Active Delivery System Market Share by Region (2021-2026) Table 15. Global Skin Active Delivery System Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Skin Active Delivery System Market Share by Region (2027-2032) Table 17. Global Skin Active Delivery System Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Skin Active Delivery System Revenue Market Share by Players (2021-2026) Table 19. Global Skin Active Delivery System Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Skin Active Delivery System Key Players Headquarters & Area Served Table 21. Global Skin Active Delivery System Players, Product Type & Application Table 22. Global Skin Active Delivery System Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Skin Active Delivery System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Skin Active Delivery System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Skin Active Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Skin Active Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Skin Active Delivery System Revenue Market Share by Type (2021-2026) Table 29. Global Skin Active Delivery System Revenue Market Share by Type (2027-2032) Table 30. Global Skin Active Delivery System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Skin Active Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Skin Active Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Skin Active Delivery System Revenue Market Share by Application (2021-2026) Table 34. Global Skin Active Delivery System Revenue Market Share by Application (2027-2032) Table 35. KINDEVA Company Information Table 36. KINDEVA Business Overview Table 37. KINDEVA Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. KINDEVA Skin Active Delivery System Product Portfolio Table 39. KINDEVA Recent Development Table 40. Zosano Pharma Company Information Table 41. Zosano Pharma Business Overview Table 42. Zosano Pharma Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Zosano Pharma Skin Active Delivery System Product Portfolio Table 44. Zosano Pharma Recent Development Table 45. Becton-Dickinson(BD)Technologies Company Information Table 46. Becton-Dickinson(BD)Technologies Business Overview Table 47. Becton-Dickinson(BD)Technologies Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Becton-Dickinson(BD)Technologies Skin Active Delivery System Product Portfolio Table 49. Becton-Dickinson(BD)Technologies Recent Development Table 50. Corium Company Information Table 51. Corium Business Overview Table 52. Corium Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Corium Skin Active Delivery System Product Portfolio Table 54. Corium Recent Development Table 55. Nitto Company Information Table 56. Nitto Business Overview Table 57. Nitto Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Nitto Skin Active Delivery System Product Portfolio Table 59. Nitto Recent Development Table 60. Valeritas Company Information Table 61. Valeritas Business Overview Table 62. Valeritas Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Valeritas Skin Active Delivery System Product Portfolio Table 64. Valeritas Recent Development Table 65. Nanopass Technologies Company Information Table 66. Nanopass Technologies Business Overview Table 67. Nanopass Technologies Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Nanopass Technologies Skin Active Delivery System Product Portfolio Table 69. Nanopass Technologies Recent Development Table 70. TheraJect, Inc Company Information Table 71. TheraJect, Inc Business Overview Table 72. TheraJect, Inc Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. TheraJect, Inc Skin Active Delivery System Product Portfolio Table 74. TheraJect, Inc Recent Development Table 75. Vaxxas Company Information Table 76. Vaxxas Business Overview Table 77. Vaxxas Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Vaxxas Skin Active Delivery System Product Portfolio Table 79. Vaxxas Recent Development Table 80. Microdermics Company Information Table 81. Microdermics Business Overview Table 82. Microdermics Skin Active Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Microdermics Skin Active Delivery System Product Portfolio Table 84. Microdermics Recent Development Table 85. Lohmann Therapie-Systeme AG Company Information Table 86. Lohmann Therapie-Systeme AG Business Overview Table 87. Lohmann Therapie-Systeme AG Skin Active Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Lohmann Therapie-Systeme AG Skin Active Delivery System Product Portfolio Table 89. Lohmann Therapie-Systeme AG Recent Development Table 90. BASF Company Information Table 91. BASF Business Overview Table 92. BASF Skin Active Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. BASF Skin Active Delivery System Product Portfolio Table 94. BASF Recent Development Table 95. 3M Company Information Table 96. 3M Business Overview Table 97. 3M Skin Active Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. 3M Skin Active Delivery System Product Portfolio Table 99. 3M Recent Development Table 100. Evonik Personal Care Company Information Table 101. Evonik Personal Care Business Overview Table 102. Evonik Personal Care Skin Active Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Evonik Personal Care Skin Active Delivery System Product Portfolio Table 104. Evonik Personal Care Recent Development Table 105. Vantage Personal Care Company Information Table 106. Vantage Personal Care Business Overview Table 107. Vantage Personal Care Skin Active Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Vantage Personal Care Skin Active Delivery System Product Portfolio Table 109. Vantage Personal Care Recent Development Table 110. Minerals Technologies Company Information Table 111. Minerals Technologies Business Overview Table 112. Minerals Technologies Skin Active Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Minerals Technologies Skin Active Delivery System Product Portfolio Table 114. Minerals Technologies Recent Development Table 115. Bicosome Company Information Table 116. Bicosome Business Overview Table 117. Bicosome Skin Active Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Bicosome Skin Active Delivery System Product Portfolio Table 119. Bicosome Recent Development Table 120. North America Skin Active Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Skin Active Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Skin Active Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Skin Active Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Skin Active Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Skin Active Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Skin Active Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Skin Active Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Skin Active Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Skin Active Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Skin Active Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Skin Active Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Skin Active Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Skin Active Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 134. China Skin Active Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 135. China Skin Active Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 136. China Skin Active Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 137. China Skin Active Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Skin Active Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Skin Active Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Skin Active Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Skin Active Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Skin Active Delivery System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Skin Active Delivery System Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Skin Active Delivery System Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Skin Active Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Skin Active Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Skin Active Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Skin Active Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Skin Active Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Skin Active Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Skin Active Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Skin Active Delivery System Image Figure 2. Global Skin Active Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Skin Active Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microcapsules Image Figure 5. Base Oil Image Figure 6. Microneedle Technology Image Figure 7. Global Skin Active Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Skin Active Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Image Figure 10. Cosmetic Image Figure 11. Global Skin Active Delivery System Market Size (US$ Million) & (2021-2032) Figure 12. Global Skin Active Delivery System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Skin Active Delivery System Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Skin Active Delivery System Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Skin Active Delivery System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Skin Active Delivery System Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Skin Active Delivery System Revenue Market Share by Type (2021-2032) Figure 19. Global Skin Active Delivery System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Skin Active Delivery System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Skin Active Delivery System Revenue Market Share by Application (2021-2032) Figure 22. North America Skin Active Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Skin Active Delivery System Revenue Share by Type (2021-2032) Figure 24. North America Skin Active Delivery System Revenue Share by Application (2021-2032) Figure 25. North America Skin Active Delivery System Revenue Share by Country (2021-2032) Figure 26. United States Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Skin Active Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Skin Active Delivery System Revenue Share by Type (2021-2032) Figure 31. Europe Skin Active Delivery System Revenue Share by Application (2021-2032) Figure 32. Europe Skin Active Delivery System Revenue Share by Country (2021-2032) Figure 33. Germany Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Skin Active Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Skin Active Delivery System Revenue Share by Type (2021-2032) Figure 43. China Skin Active Delivery System Revenue Share by Application (2021-2032) Figure 44. Asia Skin Active Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Skin Active Delivery System Revenue Share by Type (2021-2032) Figure 46. Asia Skin Active Delivery System Revenue Share by Application (2021-2032) Figure 47. Asia Skin Active Delivery System Revenue Share by Region (2021-2032) Figure 48. Japan Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Skin Active Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Skin Active Delivery System Revenue Share by Type (2021-2032) Figure 56. SAMEA Skin Active Delivery System Revenue Share by Application (2021-2032) Figure 57. SAMEA Skin Active Delivery System Revenue Share by Country (2021-2032) Figure 58. Brazil Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Skin Active Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Microcapsules
  • Base Oil
  • Microneedle Technology
Applications
  • Drug
  • Cosmetic
Companies covered
  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson(BD)Technologies
  • Corium
  • Nitto
  • Valeritas
  • Nanopass Technologies
  • TheraJect, Inc
  • Vaxxas
  • Microdermics
  • Lohmann Therapie-Systeme AG
  • BASF
  • 3M
  • Evonik Personal Care
  • Vantage Personal Care
  • Minerals Technologies
  • Bicosome

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Skin Active Delivery System Market by Type
  3. 1.2.1 Global Skin Active Delivery System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microcapsules
  5. 1.2.3 Base Oil
  6. 1.2.4 Microneedle Technology
  7. 1.3 Skin Active Delivery System Market by Application
  8. 1.3.1 Global Skin Active Delivery System Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug
  10. 1.3.3 Cosmetic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Skin Active Delivery System Market Dynamics
  1. 2.1 Skin Active Delivery System Industry Trends
  2. 2.2 Skin Active Delivery System Industry Drivers
  3. 2.3 Skin Active Delivery System Industry Opportunities and Challenges
  4. 2.4 Skin Active Delivery System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Skin Active Delivery System Market Perspective (2021-2032)
  2. 3.2 Global Skin Active Delivery System Growth Trends by Region
  3. 3.2.1 Global Skin Active Delivery System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Skin Active Delivery System Market Size by Region (2021-2026)
  5. 3.2.3 Global Skin Active Delivery System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Skin Active Delivery System Revenue by Players
  2. 4.1.1 Global Skin Active Delivery System Revenue by Players (2021-2026)
  3. 4.1.2 Global Skin Active Delivery System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Skin Active Delivery System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Skin Active Delivery System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Skin Active Delivery System Key Players Headquarters & Area Served
  7. 4.4 Global Skin Active Delivery System Players, Product Type & Application
  8. 4.5 Global Skin Active Delivery System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Skin Active Delivery System Market CR5 and HHI
  11. 4.6.3 2025 Skin Active Delivery System Tier 1, Tier 2, and Tier 3
5 Skin Active Delivery System Market Size by Type
  1. 5.1 Global Skin Active Delivery System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Skin Active Delivery System Revenue by Type (2021-2032)
  3. 5.3 Global Skin Active Delivery System Revenue Market Share by Type (2021-2032)
6 Skin Active Delivery System Market Size by Application
  1. 6.1 Global Skin Active Delivery System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Skin Active Delivery System Revenue by Application (2021-2032)
  3. 6.3 Global Skin Active Delivery System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 KINDEVA
  2. 7.1.1 KINDEVA Company Information
  3. 7.1.2 KINDEVA Business Overview
  4. 7.1.3 KINDEVA Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 KINDEVA Skin Active Delivery System Product Portfolio
  6. 7.1.5 KINDEVA Recent Developments
  7. 7.2 Zosano Pharma
  8. 7.2.1 Zosano Pharma Company Information
  9. 7.2.2 Zosano Pharma Business Overview
  10. 7.2.3 Zosano Pharma Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zosano Pharma Skin Active Delivery System Product Portfolio
  12. 7.2.5 Zosano Pharma Recent Developments
  13. 7.3 Becton-Dickinson(BD)Technologies
  14. 7.3.1 Becton-Dickinson(BD)Technologies Company Information
  15. 7.3.2 Becton-Dickinson(BD)Technologies Business Overview
  16. 7.3.3 Becton-Dickinson(BD)Technologies Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Becton-Dickinson(BD)Technologies Skin Active Delivery System Product Portfolio
  18. 7.3.5 Becton-Dickinson(BD)Technologies Recent Developments
  19. 7.4 Corium
  20. 7.4.1 Corium Company Information
  21. 7.4.2 Corium Business Overview
  22. 7.4.3 Corium Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Corium Skin Active Delivery System Product Portfolio
  24. 7.4.5 Corium Recent Developments
  25. 7.5 Nitto
  26. 7.5.1 Nitto Company Information
  27. 7.5.2 Nitto Business Overview
  28. 7.5.3 Nitto Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Nitto Skin Active Delivery System Product Portfolio
  30. 7.5.5 Nitto Recent Developments
  31. 7.6 Valeritas
  32. 7.6.1 Valeritas Company Information
  33. 7.6.2 Valeritas Business Overview
  34. 7.6.3 Valeritas Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Valeritas Skin Active Delivery System Product Portfolio
  36. 7.6.5 Valeritas Recent Developments
  37. 7.7 Nanopass Technologies
  38. 7.7.1 Nanopass Technologies Company Information
  39. 7.7.2 Nanopass Technologies Business Overview
  40. 7.7.3 Nanopass Technologies Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nanopass Technologies Skin Active Delivery System Product Portfolio
  42. 7.7.5 Nanopass Technologies Recent Developments
  43. 7.8 TheraJect, Inc
  44. 7.8.1 TheraJect, Inc Company Information
  45. 7.8.2 TheraJect, Inc Business Overview
  46. 7.8.3 TheraJect, Inc Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 TheraJect, Inc Skin Active Delivery System Product Portfolio
  48. 7.8.5 TheraJect, Inc Recent Developments
  49. 7.9 Vaxxas
  50. 7.9.1 Vaxxas Company Information
  51. 7.9.2 Vaxxas Business Overview
  52. 7.9.3 Vaxxas Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Vaxxas Skin Active Delivery System Product Portfolio
  54. 7.9.5 Vaxxas Recent Developments
  55. 7.10 Microdermics
  56. 7.10.1 Microdermics Company Information
  57. 7.10.2 Microdermics Business Overview
  58. 7.10.3 Microdermics Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Microdermics Skin Active Delivery System Product Portfolio
  60. 7.10.5 Microdermics Recent Developments
  61. 7.11 Lohmann Therapie-Systeme AG
  62. 7.11.1 Lohmann Therapie-Systeme AG Company Information
  63. 7.11.2 Lohmann Therapie-Systeme AG Business Overview
  64. 7.11.3 Lohmann Therapie-Systeme AG Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lohmann Therapie-Systeme AG Skin Active Delivery System Product Portfolio
  66. 7.11.5 Lohmann Therapie-Systeme AG Recent Developments
  67. 7.12 BASF
  68. 7.12.1 BASF Company Information
  69. 7.12.2 BASF Business Overview
  70. 7.12.3 BASF Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 BASF Skin Active Delivery System Product Portfolio
  72. 7.12.5 BASF Recent Developments
  73. 7.13 3M
  74. 7.13.1 3M Company Information
  75. 7.13.2 3M Business Overview
  76. 7.13.3 3M Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 3M Skin Active Delivery System Product Portfolio
  78. 7.13.5 3M Recent Developments
  79. 7.14 Evonik Personal Care
  80. 7.14.1 Evonik Personal Care Company Information
  81. 7.14.2 Evonik Personal Care Business Overview
  82. 7.14.3 Evonik Personal Care Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Evonik Personal Care Skin Active Delivery System Product Portfolio
  84. 7.14.5 Evonik Personal Care Recent Developments
  85. 7.15 Vantage Personal Care
  86. 7.15.1 Vantage Personal Care Company Information
  87. 7.15.2 Vantage Personal Care Business Overview
  88. 7.15.3 Vantage Personal Care Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Vantage Personal Care Skin Active Delivery System Product Portfolio
  90. 7.15.5 Vantage Personal Care Recent Developments
  91. 7.16 Minerals Technologies
  92. 7.16.1 Minerals Technologies Company Information
  93. 7.16.2 Minerals Technologies Business Overview
  94. 7.16.3 Minerals Technologies Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Minerals Technologies Skin Active Delivery System Product Portfolio
  96. 7.16.5 Minerals Technologies Recent Developments
  97. 7.17 Bicosome
  98. 7.17.1 Bicosome Company Information
  99. 7.17.2 Bicosome Business Overview
  100. 7.17.3 Bicosome Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Bicosome Skin Active Delivery System Product Portfolio
  102. 7.17.5 Bicosome Recent Developments
8 North America
  1. 8.1 North America Skin Active Delivery System Revenue (2021-2032)
  2. 8.2 North America Skin Active Delivery System Revenue by Type (2021-2032)
  3. 8.2.1 North America Skin Active Delivery System Revenue by Type (2021-2026)
  4. 8.2.2 North America Skin Active Delivery System Revenue by Type (2027-2032)
  5. 8.3 North America Skin Active Delivery System Revenue Share by Type (2021-2032)
  6. 8.4 North America Skin Active Delivery System Revenue by Application (2021-2032)
  7. 8.4.1 North America Skin Active Delivery System Revenue by Application (2021-2026)
  8. 8.4.2 North America Skin Active Delivery System Revenue by Application (2027-2032)
  9. 8.5 North America Skin Active Delivery System Revenue Share by Application (2021-2032)
  10. 8.6 North America Skin Active Delivery System Revenue by Country
  11. 8.6.1 North America Skin Active Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Skin Active Delivery System Revenue by Country (2021-2026)
  13. 8.6.3 North America Skin Active Delivery System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Skin Active Delivery System Revenue (2021-2032)
  2. 9.2 Europe Skin Active Delivery System Revenue by Type (2021-2032)
  3. 9.2.1 Europe Skin Active Delivery System Revenue by Type (2021-2026)
  4. 9.2.2 Europe Skin Active Delivery System Revenue by Type (2027-2032)
  5. 9.3 Europe Skin Active Delivery System Revenue Share by Type (2021-2032)
  6. 9.4 Europe Skin Active Delivery System Revenue by Application (2021-2032)
  7. 9.4.1 Europe Skin Active Delivery System Revenue by Application (2021-2026)
  8. 9.4.2 Europe Skin Active Delivery System Revenue by Application (2027-2032)
  9. 9.5 Europe Skin Active Delivery System Revenue Share by Application (2021-2032)
  10. 9.6 Europe Skin Active Delivery System Revenue by Country
  11. 9.6.1 Europe Skin Active Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Skin Active Delivery System Revenue by Country (2021-2026)
  13. 9.6.3 Europe Skin Active Delivery System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Skin Active Delivery System Revenue (2021-2032)
  2. 10.2 China Skin Active Delivery System Revenue by Type (2021-2032)
  3. 10.2.1 China Skin Active Delivery System Revenue by Type (2021-2026)
  4. 10.2.2 China Skin Active Delivery System Revenue by Type (2027-2032)
  5. 10.3 China Skin Active Delivery System Revenue Share by Type (2021-2032)
  6. 10.4 China Skin Active Delivery System Revenue by Application (2021-2032)
  7. 10.4.1 China Skin Active Delivery System Revenue by Application (2021-2026)
  8. 10.4.2 China Skin Active Delivery System Revenue by Application (2027-2032)
  9. 10.5 China Skin Active Delivery System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Skin Active Delivery System Revenue (2021-2032)
  2. 11.2 Asia Skin Active Delivery System Revenue by Type (2021-2032)
  3. 11.2.1 Asia Skin Active Delivery System Revenue by Type (2021-2026)
  4. 11.2.2 Asia Skin Active Delivery System Revenue by Type (2027-2032)
  5. 11.3 Asia Skin Active Delivery System Revenue Share by Type (2021-2032)
  6. 11.4 Asia Skin Active Delivery System Revenue by Application (2021-2032)
  7. 11.4.1 Asia Skin Active Delivery System Revenue by Application (2021-2026)
  8. 11.4.2 Asia Skin Active Delivery System Revenue by Application (2027-2032)
  9. 11.5 Asia Skin Active Delivery System Revenue Share by Application (2021-2032)
  10. 11.6 Asia Skin Active Delivery System Revenue by Country
  11. 11.6.1 Asia Skin Active Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Skin Active Delivery System Revenue by Country (2021-2026)
  13. 11.6.3 Asia Skin Active Delivery System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Skin Active Delivery System Revenue (2021-2032)
  2. 12.2 SAMEA Skin Active Delivery System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Skin Active Delivery System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Skin Active Delivery System Revenue by Type (2027-2032)
  5. 12.3 SAMEA Skin Active Delivery System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Skin Active Delivery System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Skin Active Delivery System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Skin Active Delivery System Revenue by Application (2027-2032)
  9. 12.5 SAMEA Skin Active Delivery System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Skin Active Delivery System Revenue by Country
  11. 12.6.1 SAMEA Skin Active Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Skin Active Delivery System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Skin Active Delivery System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst